$5.66
4.9%
Price vs. AI Score (Last 150 days)
Data gathered: December 1
Data gathered: December 1
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 1 0% |
|
| Sentiment | 100 0% |
|
| Webpage traffic | 21,000 -14.2% |
|
| Employee Rating | 65 0% |
|
| Linkedin Employees | 162 N/A |
|
| Patents | 45 2.3% |
|
| 4chan Mentions | 0% | N/A |
| Stocktwits Mentions | 9 -18.2% |
|
| Stocktwits Subscribers | 2,141 -0.1% |
|
| Twitter Followers | 6,391 0.1% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 40 0% |
|
In the news
 |
Caribou Biosciences: Upcoming CB-010 Data Could Send The Bears PackingNovember 26 - SeekingAlpha |
Caribou wins FDA orphan drug status for CAR-T therapyNovember 21 - Seeking Alpha |
|
Caribou Biosciences multiple myeloma treatment granted FDA orphan statusNovember 21 - Thefly.com |
|
 |
Does Caribou Biosciences, Inc. (CRBU) Have the Potential to Rally 321.46% as Wall Street Analysts Expect?November 19 - Yahoo |
 |
Subdued Growth No Barrier To Caribou Biosciences, Inc. (NASDAQ:CRBU) With Shares Advancing 28%November 17 - Yahoo |
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On FridayNovember 16 - Benzinga |
|
About Caribou Biosciences
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally.
| Price | $5.66 |
| Target Price | Sign up |
| Market Cap | $527M |
| Dividend Yield | 0 |
| Industry | Medical Devices |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 24M | 9.7M | 14M | -10M | -15M |
| Q2 '23 | 3.8M | 10M | -6.4M | -30M | -33M |
| Q1 '23 | 3.5M | 8.9M | -5.4M | -28M | -31M |
| Q4 '22 | 8.3M | 8.5M | -240,000 | -27M | -31M |
| Q3 '22 | 3.3M | 9.8M | -6.5M | -27M | -26M |
Insider Transactions
| Rizvi Syed Ali-aamir filed to sell 59,373 shares at $6.3. January 20 '23 |
Read more about Caribou Biosciences and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, linkedin employees, patents, 4chan mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, reddit mentions, business outlook.